EMERGENT BIOSOLUTIONS INC. (EBS) Operating cash flow 2016–2025
EMERGENT BIOSOLUTIONS INC. (EBS) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
$170.6MFY2025 · since FY2016: $54.6M → $170.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $170.6M | +190.6% |
| FY2024 | $58.7M | +128.5% |
| FY2023 | -$206.3M | -505.0% |
| FY2022 | -$34.1M | -110.6% |
| FY2021 | $320.2M | -40.4% |
| FY2020 | $536.9M | +185.6% |
| FY2019 | $188.0M | +349.8% |
| FY2018 | $41.8M | -79.9% |
| FY2017 | $208.1M | +281.1% |
| FY2016 | $54.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice